Please view information on the current medication shortage here.

Shortage Methylphenidate Hydrochloride MR (2024)​

national and global shortage of elvanse and atomoxetine adhd direct
Picture of ADHD Direct

ADHD Direct

Facebook
Twitter
Email
WhatsApp

On this post:

Published: September 14, 2023
Last updated: June 7, 2024

Important Update: Methylphenidate Hydrochloride XL (12-Hour) Tablet Shortage 

We wish to inform our patients about an ongoing medication shortage that may affect your treatment. All strengths of Methylphenidate Hydrochloride XL (12-hour) Tablets, which are commonly used for ADHD treatment, are currently in short supply. This includes medications branded as Concerta XL, Delmosart, Xaggitin XL, and Xenidate XL.  
The stock issues are not expected to be resolved until September 2024. 

What This Means for You: 

  • Current Patients: If you are experiencing difficulty obtaining your usual ADHD medication due to this shortage, we understand the challenges and frustration this may cause. If you require an alternative medication / dose because of the ADHD medication shortages, we recommend you book our TOMIS service. After filling out the online form, we will help you find an alternative medication. Replies are usually provided within 7 days of submitting the form. 

How to Schedule a TOMIS Appointment: 

To book The Online Medication Intervention Service, please visit our appointment scheduling page. Our team is here to support you and ensure that your treatment needs are met during this period. 

We apologise for any inconvenience this shortage may cause and appreciate your understanding and patience. 

We would also like to emphasise that our service and our team have no influence over the shortage and the current situation. Please be assured that our team is working diligently to support all patients through this challenging time. 

Your health and well-being are our top priority. 

 

Sincerely  

Dr Georgina Brown 

MBCHB MRCGP DFFP SMN Mediation 
PG Diploma Clinical Psychiatry (Merit) 
PG Certificate Attention Deficit Hyperactivity Disorder 

Medicine Supply Notification: Lisdexamfetamine (Elvanse®) capsules 

According to Community Pharmacy England, the Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lisdexamfetamine (Elvanse®) capsules 

MSN/2024/051 

Tier 3 high impact 

Date of issue: 8th May 2024 

  • All strengths of Elvanse® capsules are now available and an improved level of supply will continue across the majority of Elvanse® and Elvanse Adult® presentations. 
  • There will however be intermittent supply issues with Elvanse® 40mg, Elvanse® Adult 40mg and Elvanse® 60mg capsules until August 2024. 
  • Elvanse® 20mg capsules remain available, but, cannot support an increase in demand during shortages of Elvanse® 40mg, Elvanse® Adult 40mg and Elvanse® 60mg capsules 
  • Elvanse® 30mg capsules remain available and can support an increase in demand during the shortage of Elvanse 60mg capsules. 
  • Unlicensed supplies of lisdexamfetamine capsules can be sourced, lead times vary. 
  • Generic dexamfetamine 5mg tablets and Amfexa (dexamfetamine) 5mg, 10mg, and 20mg tablets remain available but are unable meet large increases in demand. 

We have been informed that the current Methylphenidate Hydrochloride MR  (the 12-hour Tablets) in all strengths are in  very limited supply or currently unavailable

Examples of these are:

  • Matoride
  • Concerta XL
  • Xaggitin XL
  • Xenidate XL
  • Delmosart
  • Affenid

Again, disappointingly there appears to have been no warning about this in advance of the shortages, and also no communication from the relevant drug companies.

 

As you are aware multiple drug companies produce Methylphenidate Hydrochloride MR  and so we are unsure of the exact reasons for this;  however, as an alternative, there is current availability of Methylphenidate Hydrochloride Capsules, which are an 8 hourly preparation with no current shortages. 

We have also directly confirmed this with the relevant Drug company representative.

 

As such if the shortages continue please do not hesitate to get in contact with us and we will aim to change your prescription to an available preparation.

 

It will likely be a capsule form (instead of a tablet),  and also it may be that whilst shortages persist you may need 2 types of methylphenidate to ensure you have good daily treatment for your ADHD symptoms.

 

However, clinicians will ensure they review all records individually to find the best treatment plan for you.

 

Dr Georgina Brown

Clinical Governance Lead

ADHD Direct

ADHD Medications affected by the shortage

Methylphenidate:

• Equasym XL® 10, 20 and 30 mg capsules 

• Xaggitin XL® 18 and 36 mg prolonged-release tablets 

• Xenidate XL® 27 mg prolonged-release tablets 

Lisdexamfetamine: 

• Elvanse® 20, 30, 40, 50, 60 and 70 mg capsules 

• Elvanse® Adult 30, 50, and 70 mg capsules 

Guanfacine: 

• Intuniv® 1, 2, 3 and 4 mg prolonged-release tablets 


The shortages are due to the disruption of these products caused by a combination of manufacturing issues and increased global demand. You can find further details on the availability on the SPS website

Expected stock availability:

Vyvanse® & Intuniv®:

Unlicensed imports of lisdexamfetamine (Vyvanse®) capsules and guanfacine (Intuniv®) prolonged-release tablets have been sourced.  

Equasym XL®:

Limited parallel imports of methylphenidate (Equasym XL®) modified release capsules remain available.

Atomoxetine:

The supply issue with atomoxetine is set to be resolved in October 2023.

Subscribe here to receive emails with updates on the situation:

Next steps:

If your medication is currently affected by the shortage and you require a prescription, you have the following options:  

  1. Get the prescriptions sent directly to your home or pick it up in our clinic and contact local pharmacies. Some pharmacies might have stock left or restock small amounts.

  2. Wait until your medication is back in stock. 

Getting a new prescription 

You can ask our team to email you a copy of your prescription prior to posting it. Some pharmacies require a copy of the prescription to reserve the medication. 

Book a medication review

Book your medication review today. Medication reviews are available as virtual appointments and as in-person appointments in our clinic in Glasgow

Transfer your care to ADHD Direct

Transfer your Care is a service developed to support patients already diagnosed with ADHD (by either NHS or other Private providers), to transfer to ADHD Direct for treatment and ongoing care (without having to go through a repeated diagnostic assessment.)
Picture of ADHD Direct

ADHD Direct

On this post:

adhd direct traveller's guide traveling with adhd
ADHD
ADHD Direct

The ADHD Direct Traveller’s Guide

Travelling can be an exhilarating experience, offering new sights, cultures, and experiences. However, for individuals with ADHD (Attention Deficit Hyperactivity Disorder), travel presents a unique

Read More »